Posted by admin on Jul 24th, 2022

Kimberly-Clark (NYSE:KMB – Get Rating) had its price target dropped by equities researchers at UBS Group to $136.00 in a report released on Friday, Stock Target Advisor reports. UBS Group’s price target indicates a potential upside of 2.72% from the company’s current price.

KMB has been the topic of a number of other reports. The Goldman Sachs Group cut their price target on Kimberly-Clark from $130.00 to $124.00 in a research note on Tuesday, March 29th. Barclays cut their price target on Kimberly-Clark from $129.00 to $124.00 and set an “equal weight” rating on the stock in a research note on Monday, May 23rd. Royal Bank of Canada raised their price objective on Kimberly-Clark from $122.00 to $124.00 and gave the stock a “sector perform” rating in a report on Monday, April 25th. StockNews.com lowered Kimberly-Clark from a “buy” rating to a “hold” rating in a report on Thursday, June 30th. Finally, JPMorgan Chase & Co. dropped their price objective on Kimberly-Clark from $118.00 to $113.00 in a report on Wednesday, March 30th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $130.71.

Shares of NYSE KMB opened at $132.40 on Friday. Kimberly-Clark has a 12-month low of $117.32 and a 12-month high of $145.79. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 9.49. The stock has a market cap of $44.61 billion, a P/E ratio of 25.51, a PEG ratio of 4.50 and a beta of 0.33. The business’s fifty day simple moving average is $131.62 and its 200-day simple moving average is $131.81.

Kimberly-Clark (NYSE:KMB – Get Rating) last posted its quarterly earnings results on Friday, April 22nd. The company reported $1.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.23 by $0.12. Kimberly-Clark had a return on equity of 253.93% and a net margin of 8.86%. The company had revenue of $5.10 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same period last year, the firm earned $1.80 earnings per share. Kimberly-Clark’s quarterly revenue was up 7.4% on a year-over-year basis. As a group, equities analysts predict that Kimberly-Clark will post 5.8 EPS for the current fiscal year.

In related news, insider Tristram Wilkinson sold 2,069 shares of the firm’s stock in a transaction dated Thursday, May 5th. The shares were sold at an average price of $137.17, for a total value of $283,804.73. Following the completion of the sale, the insider now owns 14,102 shares in the company, valued at $1,934,371.34. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, insider Jeffrey P. Melucci sold 15,302 shares of the firm’s stock in a transaction dated Monday, April 25th. The shares were sold at an average price of $142.63, for a total value of $2,182,524.26. Following the completion of the sale, the insider now owns 27,626 shares in the company, valued at $3,940,296.38. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Tristram Wilkinson sold 2,069 shares of Kimberly-Clark stock in a transaction that occurred on Thursday, May 5th. The shares were sold at an average price of $137.17, for a total transaction of $283,804.73. Following the sale, the insider now owns 14,102 shares of the company’s stock, valued at $1,934,371.34. The disclosure for this sale can be found here. Insiders sold a total of 62,696 shares of company stock worth $8,807,911 over the last 90 days. Company insiders own 0.55% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Spire Wealth Management lifted its position in shares of Kimberly-Clark by 22.2% during the 2nd quarter. Spire Wealth Management now owns 2,798 shares of the company’s stock valued at $378,000 after acquiring an additional 509 shares during the period. Bell & Brown Wealth Advisors LLC raised its position in shares of Kimberly-Clark by 4.9% during the 2nd quarter. Bell & Brown Wealth Advisors LLC now owns 13,032 shares of the company’s stock worth $1,761,000 after purchasing an additional 605 shares during the last quarter. First Bank & Trust raised its position in shares of Kimberly-Clark by 45.3% during the 2nd quarter. First Bank & Trust now owns 11,714 shares of the company’s stock worth $1,583,000 after purchasing an additional 3,653 shares during the last quarter. Retirement Guys Formula LLC raised its position in shares of Kimberly-Clark by 44.8% during the 2nd quarter. Retirement Guys Formula LLC now owns 2,630 shares of the company’s stock worth $355,000 after purchasing an additional 814 shares during the last quarter. Finally, Costello Asset Management INC raised its position in shares of Kimberly-Clark by 5.2% during the 2nd quarter. Costello Asset Management INC now owns 20,516 shares of the company’s stock worth $2,773,000 after purchasing an additional 1,012 shares during the last quarter. 74.32% of the stock is currently owned by institutional investors and hedge funds.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names.

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.

Interpublic Group of Companies (NYSE:IPG) PT Lowered to $39.00

Kestra Advisory Services LLC Acquires Shares of 5,417 Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)